Skip to main content
An official website of the United States government
Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Funded Prevention Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Howitt, Brooke E

Stanford University
United States

Unraveling heterogeneity in endometrial cancer via integrated single cell genotype-phenotype mapping 1R37CA303960-01 Goli Samimi, Ph.D., M.P.H.
Huang, Ying

Western University Of Health Sciences
United States

Preventing UV-induced immunosuppression and skin carcinogenesis with R-carvedilol 5R01CA269653-04 Anda Vlad, M.D., Ph.D.
Huh, Warner King

University Of Alabama At Birmingham
United States

Misoprostol to Optimize Prevention of Cancer of the Cervix: A Randomized Trial (MISOPCx Project) 3R01CA279021-02S1 Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Hutson, Alan David

Roswell Park Cancer Institute Corp
United States

Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center 1U24CA305623-01 Altaf Mohammed, Ph.D.
Huttenhower, Curtis

Broad Institute, Inc.
United States

PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors 3OT2CA297578-01S1 Asad Umar, D.V.M., Ph.D.
Jacob, Jennifer B

Henry Ford Health + Michigan State University Health Sciences
United States

Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice 5R01CA278818-03
Ji, Hanlee P

Stanford University
United States

Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification 5P01CA265772-03 Asad Umar, D.V.M., Ph.D.
Jiang, Qing

Purdue University
United States

Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model 5R03CA283236-02 Amit Kumar, Ph.D.
Jobin, Christian

University Of Florida
United States

Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer 1R01CA296643-01 Young Kim, Ph.D.
Johnson, Jeremy James

University Of Illinois At Chicago
United States

Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer 5R37CA227101-07 Amit Kumar, Ph.D.
Kassie, Fekadu

University Of Minnesota
United States

Targeting tumor cell mitochondria for the prevention and treatment of lung cancer 1R01CA285608-01A1
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Northwestern Cancer Prevention Consortium 2UG1CA242643-07 Donald Johnsey
Khan, Seema Ahsan

Northwestern University At Chicago
United States

Determinants of transdermal drug delivery to the normal and the radiated breast 5R01CA235647-05 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kim, Hyung L

Cedars-Sinai Medical Center
United States

Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer 5R01CA280060-03 Howard L. Parnes, M.D.
Klopp, Ann

University Of Tx Md Anderson Can Ctr
United States

Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer 1R01CA301124-01 Goli Samimi, Ph.D., M.P.H.